About Annovis Bio, Inc.
https://www.annovisbio.comAnnovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.
CEO
Maria L. Maccecchini
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:738K
Value:$2.39M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:218.42K
Value:$707.68K
GEODE CAPITAL MANAGEMENT, LLC
Shares:184.15K
Value:$596.66K
Summary
Showing Top 3 of 49
About Annovis Bio, Inc.
https://www.annovisbio.comAnnovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $7.43M ▲ | $-7.26M ▼ | 0% | $-0.37 ▼ | $-7.26M ▼ |
| Q2-2025 | $0 | $6.27M ▼ | $-6.22M ▼ | 0% | $-0.32 | $-6.27M ▲ |
| Q1-2025 | $0 | $6.28M ▼ | $-5.54M ▲ | 0% | $-0.32 ▲ | $-6.28M ▲ |
| Q4-2024 | $0 | $6.73M ▲ | $-5.86M ▲ | 0% | $-0.43 ▲ | $-6.73M ▼ |
| Q3-2024 | $0 | $4.39M | $-12.64M | 0% | $-0.97 | $-4.39M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $15.29M ▼ | $17.19M ▼ | $4.03M ▲ | $13.16M ▼ |
| Q2-2025 | $17.13M ▼ | $21.45M ▼ | $3.12M ▲ | $18.33M ▼ |
| Q1-2025 | $22.24M ▲ | $26.74M ▲ | $2.68M ▼ | $24.05M ▲ |
| Q4-2024 | $10.55M ▼ | $13.93M ▼ | $4.62M ▼ | $9.31M ▲ |
| Q3-2024 | $12.64M | $14.36M | $7.3M | $7.06M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-7.26M ▼ | $-3.49M ▲ | $0 | $1.64M ▲ | $-1.84M ▲ | $-3.49M ▲ |
| Q2-2025 | $-6.22M ▼ | $-5.11M ▲ | $0 | $0 ▼ | $-5.11M ▼ | $-5.11M ▲ |
| Q1-2025 | $-5.54M ▲ | $-8.1M ▲ | $0 | $19.78M ▲ | $11.68M ▲ | $-8.1M ▲ |
| Q4-2024 | $-5.86M ▲ | $-8.29M ▼ | $0 | $6.2M ▼ | $-2.08M ▼ | $-8.29M ▼ |
| Q3-2024 | $-12.64M | $-3.2M | $0 | $11.84M | $8.64M | $-3.2M |
CEO
Maria L. Maccecchini
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 1 of 11
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:738K
Value:$2.39M
SUSQUEHANNA INTERNATIONAL GROUP, LLP
Shares:218.42K
Value:$707.68K
GEODE CAPITAL MANAGEMENT, LLC
Shares:184.15K
Value:$596.66K
Summary
Showing Top 3 of 49